ADAMTS4
ADAMTS4 (ADAM metallopeptidase with thrombospondin type 1 motif 4, also known as KIAA0688, ADAMTS-2 and ADMP-1) is a secreted metalloproteinase of the extracellular matrix. It cleaves the cartilage proteoglycan aggrecan and the brain extracellular matrix protein brevican. Browse Assay Genie's current range of ADAMTS4 research reagents below, or read on for the biology behind the target.
ADAMTS4 is a metalloproteinase that cleaves aggrecan, a major cartilage proteoglycan, at the Glu392-Ala393 site and may be involved in its turnover. It also cleaves cartilage oligomeric matrix protein (COMP). The NCBI Gene summary additionally describes degradation of brevican, a brain-specific extracellular matrix protein. The enzyme is secreted and localises to the extracellular space and extracellular matrix, where its substrates reside.
The ADAMTS4 gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family. Family members share a propeptide region, a metalloproteinase domain, a disintegrin-like domain and a thrombospondin type 1 (TS) motif, but differ in the number of C-terminal TS motifs and in any unique C-terminal domains. The ADAMTS4 protein lacks a C-terminal TS motif. It is made as a preproprotein that is proteolytically processed to give the mature protease. Alternative splicing produces multiple transcript variants, at least one of which encodes an isoform that is itself proteolytically processed. Mouse and rat orthologs, both named Adamts4, are annotated.
Expression of ADAMTS4 is upregulated in arthritic disease, and degradation of aggrecan may contribute to disease progression. UniProt notes that the protease may play an important role in aggrecan destruction in arthritic diseases and could be a critical factor in exacerbating neurodegeneration in Alzheimer disease. Previous gene names include a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 4. These properties make ADAMTS4 a frequent subject in studies of matrix remodelling.
ADAMTS4 expression is upregulated in arthritic disease, and its degradation of aggrecan may contribute to disease progression.
The protease cleaves aggrecan at the Glu392-Ala393 site and also cleaves COMP, making it relevant to proteoglycan turnover.
ADAMTS4 degrades brevican in the brain and could be a critical factor in exacerbating neurodegeneration in Alzheimer disease.
Lacking a C-terminal TS motif, ADAMTS4 offers a useful comparison point for how domain architecture varies across the ADAMTS family.
ADAMTS4 is a secreted metalloproteinase that cleaves aggrecan at the Glu392-Ala393 site and may be involved in aggrecan turnover. It also cleaves COMP and degrades brevican, a brain-specific extracellular matrix protein. It may contribute to aggrecan destruction in arthritic diseases.
ADAMTS4 is also called KIAA0688, ADAMTS-2 and ADMP-1. Its full name is A disintegrin and metalloproteinase with thrombospondin motifs 4, and its enzyme classification is EC 3.4.24.82. Alternative splicing gives several transcript variants, and the preproprotein is proteolytically processed to the mature protease.
ADAMTS4 expression is upregulated in arthritic disease, and the protein may be involved in neurodegeneration in Alzheimer disease. Orthologs named Adamts4 are annotated in mouse and rat; check the datasheet of any product for its validated reactivity.
Other ADAMTS family proteases and extracellular matrix-modifying enzymes with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O75173; product specifications from Assay Genie datasheets.